{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:45Z","timestamp":1761101025189},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11899-009-0031-4","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T07:16:19Z","timestamp":1254294979000},"page":"236-244","source":"Crossref","is-referenced-by-count":10,"title":["Hemopoietic stem cell transplantation in T-cell malignancies: Who, when, and how?"],"prefix":"10.1007","volume":"4","author":[{"given":"Francesco","family":"d\u2019Amore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esa","family":"Jantunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Relander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B","volume":"63","author":"J.O. Armitage","year":"1989","unstructured":"Armitage JO, Greer JP, Levine AM, et al.: Peripheral T-cell lymphoma. Cancer 1989, 63:158\u2013163.","journal-title":"Cancer"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"J.O. Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD, Non-Hodgkin\u2019s Lymphoma Classification Project: New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. J Clin Oncol 1998, 16:2780\u20132795.","journal-title":"J Clin Oncol"},{"key":"31_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11864-004-0020-8","volume":"5","author":"A.M. Evens","year":"2004","unstructured":"Evens AM, Gartenhaus RB: Treatment of non-Hodgkin\u2019s lymphoma. Curr Treat Options Oncol 2004, 5:289\u2013303.","journal-title":"Curr Treat Options Oncol"},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","volume":"87","author":"F. d\u2019Amore","year":"1996","unstructured":"d\u2019Amore F, Johansen P, Houmand A, et al.: Epstein-Barr virus genome in non-Hodgkin\u2019s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood 1996, 87:1045\u20131055.","journal-title":"Blood"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"N.L. Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting\u2014Airlie House, Virginia, November 1997. J Clin Oncol 1999, 17:3835\u20133849.","journal-title":"J Clin Oncol"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T. R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, et al.: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 2002, 13:140\u2013149.","journal-title":"Ann Oncol"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A. Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC, et al.: Evaluation of the Revised European-American Lymphoma Classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma. Blood 1997, 89:4514\u20134520.","journal-title":"Blood"},{"key":"31_CR8","first-page":"76","volume":"92","author":"C. Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, et al.: Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Blood 1998, 92:76\u201382.","journal-title":"Blood"},{"key":"31_CR9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","volume":"7","author":"J.O. Armitage","year":"1989","unstructured":"Armitage JO, Vose JM, Linder J, et al.: Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 1989, 7:1783\u20131790.","journal-title":"J Clin Oncol"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"B. Coiffier","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M, et al.: Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Group d\u2019Etudes des Lymphomes de l\u2019Adulte). Ann Oncol 1990, 1:45\u201350.","journal-title":"Ann Oncol"},{"key":"31_CR11","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"M.P. Escal\u00f3n","year":"2005","unstructured":"Escal\u00f3n MP, Liu NS, Yang Y, et al.: Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma. Cancer 2005, 103:2091\u20132098.","journal-title":"Cancer"},{"key":"31_CR12","first-page":"443","volume":"45","author":"E. Jantunen","year":"2004","unstructured":"Jantunen E, d\u2019Amore F: Stem cell transplantation for peripheral T-cell lymphomas. Leuk Lymphoma 2004, 45:443\u2013446.","journal-title":"Leuk Lymphoma"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P. Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F, et al.: Long-term follow-up of patients with peripheral T-cell lymphomas treated upfront with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006, 20:1533\u20131538.","journal-title":"Leukemia"},{"key":"31_CR14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0609.2007.00856.x","volume":"79","author":"J. Rodr\u00edguez","year":"2007","unstructured":"Rodr\u00edguez J, Conde E, Gutierrez A, et al.: Front-line autologous stem-cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from the GEL-TAMO Study Group. Eur J Haematol 2007, 79:32\u201338.","journal-title":"Eur J Haematol"},{"key":"31_CR15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S. Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, et al.: Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 2008, 19:958\u2013963.","journal-title":"Ann Oncol"},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","volume":"27","author":"P. Reimer","year":"2008","unstructured":"Reimer P, Rudiger T, Geissinger E, et al.: Autologous stemcell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol 2008, 27:106\u2013113.","journal-title":"J Clin Oncol"},{"key":"31_CR17","unstructured":"d\u2019Amore F, Relander T, Lauritzsen G, et al.: Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral T-cell lymphomas (PTCLs)\u2014overall and subtype-specific results of a phase II study from the Nordic Lymphoma Group [abstract 53]. Presented at the Annual Meeting of the European Hematology Association. Berlin, Germany; June 4\u20136, 2009."},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.bmt.1705555","volume":"39","author":"A. Gratwohl","year":"2007","unstructured":"Gratwohl A, Baldomero H, Frauerndorfer K, et al.: Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007, 39:71\u201387.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR19","doi-asserted-by":"crossref","unstructured":"Nademanee AP, Zain JM, Palmer J, et al.: The impact of disease status on the outcome of high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) for peripheral T-cell lymphoma (PTCL) [abstract 3060]. Presented at the Annual Meeting of the American Society of Hematology. Orlando, FL; Dec 9\u201312, 2006.","DOI":"10.1182\/blood.V108.11.3060.3060"},{"key":"31_CR20","doi-asserted-by":"crossref","unstructured":"Yang DH, Kim WS, Kim SJ, et al.: The clinical outcomes of autologous stem cell transplantation in peripheral T-cell lymphoma: from retrospective multicenter study in Korea [abstract 1892]. Presented at the Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8\u201311, 2007.","DOI":"10.1182\/blood.V110.11.1892.1892"},{"key":"31_CR21","doi-asserted-by":"crossref","unstructured":"Chen AI, McMillan A, Negrin RS, et al.: Long-term results of autologous hematopoietic cell transplantation (AHCT) for peripheral T-cell lymphoma: the Stanford experience [abstract 1906]. Presented at the Annual Meeting of the American Society of Hematology. Atlanta, GA; Dec 8\u201311, 2007.","DOI":"10.1182\/blood.V110.11.1906.1906"},{"key":"31_CR22","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T. Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, et al.: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 1995, 333:1540\u20131545.","journal-title":"N Engl J Med"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood.V76.2.424.424","volume":"76","author":"J.M. Vose","year":"1990","unstructured":"Vose JM, Peterson C, Bierman PJ, et al.: Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin\u2019s lymphomas. Blood 1990, 76:424\u2013431.","journal-title":"Blood"},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","volume":"23","author":"R. Fanin","year":"1999","unstructured":"Fanin R, Ruiz de Elvira MC, Sperotto A, et al.: Autologous stem cell transplantation for T cell and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric patients reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999, 23:437\u2013442.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","volume":"19","author":"J. Rodriguez","year":"2001","unstructured":"Rodriguez J, Munsell M, Yaszi S, et al.: Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001, 19:3766\u20133770.","journal-title":"J Clin Oncol"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","volume":"27","author":"A. Blystad","year":"2001","unstructured":"Blystad A, Enblad G, Kvaloy S, et al.: High-dose therapy with autologous stem cell transplantation in patients with peripheral T-cell lymphomas. Bone Marrow Transplant 2001, 27:711\u2013716.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","volume":"120","author":"K.W. Song","year":"2003","unstructured":"Song KW, Mollee P, Keating A, Crump M: Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003, 120:978\u2013985.","journal-title":"Br J Haematol"},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0609.2007.00815.x","volume":"78","author":"J. Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, et al.: Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: GELTAMO experience. Eur J Haematol 2007, 78:290\u2013296.","journal-title":"Eur J Haematol"},{"key":"31_CR29","first-page":"1272","volume":"88","author":"J. Schetelig","year":"2003","unstructured":"Schetelig J, Fetscher S, Reichle A, et al.: Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 2003, 88:1272\u20131278.","journal-title":"Haematologica"},{"key":"31_CR30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bmt.1704392","volume":"33","author":"K.W. Zamkoff","year":"2004","unstructured":"Zamkoff KW, Matulis MD, Mehta AC, et al.: High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemosensitive ALK-negative anaplastic large cell lymphoma. Bone Marrow Transplant 2004, 33:635\u2013638.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1080\/10428190412331272749","volume":"45","author":"M. Jagasia","year":"2004","unstructured":"Jagasia M, Morgan D, Goodman S, et al.: Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk Lymphoma 2004, 45:2261\u20132267.","journal-title":"Leuk Lymphoma"},{"key":"31_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1704367","volume":"33","author":"E. Jantunen","year":"2004","unstructured":"Jantunen E, Wiklund T, Juvonen E, et al.: Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey, Bone Marrow Transplant 2004, 33:405\u2013410.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2006.06164.x","volume":"134","author":"T. Kewalramani","year":"2006","unstructured":"Kewalramani T, Zelenetz AD, Teruya-Feldstein J, et al.: Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma. Br J Haematol 2006, 134:202\u2013207.","journal-title":"Br J Haematol"},{"key":"31_CR34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00277-007-0254-1","volume":"86","author":"M. Kim","year":"2007","unstructured":"Kim M, Kim S, Lee S, et al.: High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival. Ann Hematol 2007, 86:435\u2013442.","journal-title":"Ann Hematol"},{"key":"31_CR35","first-page":"1372","volume":"88","author":"J. Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, et al.: High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GELTAMO experience. Haematologica 2003, 88:1372\u20131377.","journal-title":"Haematologica"},{"key":"31_CR36","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/1042819031000123456","volume":"44","author":"E. Jantunen","year":"2003","unstructured":"Jantunen E, Juvonen E, Wiklund T, et al.: High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma. Leuk Lymphoma 2003, 44:2163\u20132164.","journal-title":"Leuk Lymphoma"},{"key":"31_CR37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","volume":"14","author":"W.Y. Au","year":"2003","unstructured":"Au WY, Lie AKW, Liang R, et al.: Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report of its value. Ann Oncol 2003, 14:1673\u20131676.","journal-title":"Ann Oncol"},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","volume":"27","author":"H.J. Kim","year":"2006","unstructured":"Kim HJ, Bang SM, Lee J, et al.: High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantational cases. Bone Marrow Transplant 2006, 27:819\u2013824.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR39","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/JCO.2000.18.16.3025","volume":"18","author":"C. Haioun","year":"2000","unstructured":"Haioun C, Lepage E, Gisselbrecht C, et al.: Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin\u2019s lymphoma: final analysis of the prospective LNH87-2 protocol\u2014A Groupe d\u2019Etude des Lymphomes de l\u2019Adulte study. J Clin Oncol 2000, 18:3025\u20133030.","journal-title":"J Clin Oncol"},{"key":"31_CR40","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2002.02.125","volume":"20","author":"C. Gisselbrecht","year":"2002","unstructured":"Gisselbrecht C, Lepage E, Molina T, et al.: Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. J Clin Oncol 2002, 20:2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"31_CR41","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/annonc\/mdh471","volume":"15","author":"N. Mounier","year":"2004","unstructured":"Mounier N, Giesselbrecht C, Briere J, et al.: All aggressive lymphoma subtypes do not share the same similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA). Ann Oncol 2004, 15:1790\u20131797.","journal-title":"Ann Oncol"},{"key":"31_CR42","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1200\/JCO.2004.12.032","volume":"22","author":"N. Mounier","year":"2004","unstructured":"Mounier N, Giesselbrecht C, Briere J, et al.: Prognostic factors in patients with aggressive non-Hodgkin\u2019s lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA). J Clin Oncol 2004, 22:2826\u20132834.","journal-title":"J Clin Oncol"},{"key":"31_CR43","first-page":"218","volume":"26","author":"C. Kyriakou","year":"2008","unstructured":"Kyriakou C, Canals C, Goldstone A, et al.: High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of outcome\u2014Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008, 26:218\u2013224.","journal-title":"J Clin Oncol"},{"key":"31_CR44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","volume":"88","author":"Y. Lee","year":"2009","unstructured":"Lee Y, Uhm JE, Lee HY, et al.: Clinical features and prognostic factors of patients with \u201cperipheral T cell lymphoma, unspecified\u201d. Ann Hematol 2009, 88:111\u2013119.","journal-title":"Ann Hematol"},{"key":"31_CR45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbmt.2008.11.010","volume":"15","author":"D.H. Yang","year":"2009","unstructured":"Yang DH, Kim WS, Kim SJ, et al.: Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome. Biol Blood Marrow Transplant 2009, 15:118\u2013125.","journal-title":"Biol Blood Marrow Transplant"},{"key":"31_CR46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2141.2000.02098.x","volume":"109","author":"E. Deconinck","year":"2000","unstructured":"Deconinck E, Lamy T, Foussard C, et al.: Autologous stem cell transplantation for anaplastic large cell lymphomas: results of a prospective trial. Br J Haematol 2000, 109:736\u2013742.","journal-title":"Br J Haematol"},{"key":"31_CR47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.dld.2007.03.009","volume":"39","author":"A. Al-Toma","year":"2007","unstructured":"Al-Toma A, Verbeek WH, Visser O, et al.: Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis 2007, 39:634\u2013641.","journal-title":"Dig Liver Dis"},{"key":"31_CR48","unstructured":"Lennard AM, White J, Tiplady C: Prospective evaluation of a novel treatment protocol for intestinal T cell NHL [abstract 43]. Presented at the International Conference on Malignant Lymphoma, Lugano, Switzerland; June 3\u20139, 2002."},{"key":"31_CR49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2006.06371.x","volume":"136","author":"M.J. Bishton","year":"2007","unstructured":"Bishton MJ, Haynes AP: Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma. Br J Haematol 2007, 136:111\u2013113.","journal-title":"Br J Haematol"},{"key":"31_CR50","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.11173","volume":"92","author":"J. Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Guti\u00e9rrez A, et al.: The adjusted international prognostic index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing\/refractory peripheral T-cell lymphoma. Haematologica 2007, 92:1067\u20131074.","journal-title":"Haematologica"},{"key":"31_CR51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","volume":"27","author":"A. Utsunomiya","year":"2001","unstructured":"Utsunomiya A, Miyazaki Y, Takatsuka Y, et al.: Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 27:15\u201320.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1701533","volume":"23","author":"K. Tsukasaki","year":"1999","unstructured":"Tsukasaki K, Maeda T, Arimura K, et al.: Poor outcome of autologous stem cell transplantation for adult T-cell leukemia\/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999, 23:87\u201389.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2006.06004.x","volume":"133","author":"W. Woessman","year":"2006","unstructured":"Woessman W, Peters C, Lenhard M, et al.: Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents\u2014a Berlin-Frankfurt-Muenster group report. Br J Haematol 2006, 133:176\u2013182.","journal-title":"Br J Haematol"},{"key":"31_CR54","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P. Corradini","year":"2004","unstructured":"Corradini P, Dodero A, Zallio F, et al.: Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin\u2019s lymphoma after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004, 22:2172\u20132176.","journal-title":"J Clin Oncol"},{"key":"31_CR55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bmt.1705036","volume":"36","author":"G.G. Wulf","year":"2005","unstructured":"Wulf GG, Hasenkamp J, Jung W, et al.: Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin\u2019s lymphoma. Bone Marrow Transplant 2005, 36:271\u2013273.","journal-title":"Bone Marrow Transplant"},{"key":"31_CR56","doi-asserted-by":"crossref","unstructured":"Corradini P, Dodero A, Bregni M, et al.: Reduced-intensity conditioning followed by allogeneic transplantation (allo SCT) is an effective salvage treatment for peripheral T-cell non-Hodgkin\u2019s lymphoma (PTCL) [abstract 328a]. Presented at the Annual Meeting of the American Society of Hematology. Atlanta, GA; December 9\u201312, 2005.","DOI":"10.1182\/blood.V106.11.1128.1128"},{"key":"31_CR57","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J. Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Guttierrez A, et al.: The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: The Spanish lymphoma and autologous transplantation group experience. Ann Oncol 2007, 18:652\u2013657.","journal-title":"Ann Oncol"},{"key":"31_CR58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bmt.1705752","volume":"40","author":"S. Feyler","year":"2007","unstructured":"Feyler S, Prince HM, Pearce R, et al.: The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 2007, 40:443\u2013450.","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-009-0031-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-009-0031-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-009-0031-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:25:01Z","timestamp":1590164701000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-009-0031-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s11899-009-0031-4","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}